DUBLIN--(BUSINESS WIRE)--The "Advanced Regulatory Affairs for Medical Devices" conference has been added to ResearchAndMarkets.com's offering. Planning your regulatory strategy to comply with the ...

The introduction of new Post-Market Surveillance regulations and UKCA marking processes presents key opportunities for medical device manufacturers to align compliance strategies and enhance market ...

The "A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU (European Union) and UK Training Course (Apr 29, 2026)" training has been added to ResearchAndMarkets.com's ...

DUBLIN--(BUSINESS WIRE)--The "Advanced Regulatory Affairs for Medical Devices" conference has been added to ResearchAndMarkets.com's offering. Planning your regulatory strategy to comply with the ...

As the saying goes, time is money, and this statement could not be more true for the medical device industry. Each day that passes when a device is not approved for marketing is a day of revenue loss.

Global Healthcare Regulatory Affairs Outsourcing Market to Expand at 9.76% CAGR as Demand for Specialized Compliance, Faster Approvals, and Cost Optimization Accelerates.Austin, Texas, Jan. 27, 2026 ...

As the biopharma space gets more competitive and the days of blockbuster drugs seem further in the rearview, biopharma companies are investing in digital to find new and innovative ways to ...

Rockville, MD, USA, Aug. 16, 2017 (GLOBE NEWSWIRE) -- The Regulatory Affairs Professionals Society (RAPS) has published the updated, 10 th edition of Fundamentals of US Regulatory Affairs, the most ...

Ever present but seldom seen, while being increasingly vital, the rapidly expanding area of the Chemistry, Manufacturing and Controls (CMC) of pharmaceutical products is gradually developing into a ...

The medical device market has grown rapidly in the past decade and shows no sign of slowing down. An increasing number of companies have tapped the Asian region to manufacture medical devices. Many ...

South Korea’s medical device market is rapidly expanding, driven by technological innovations and increasing healthcare demands. As the market grows, understanding Korean medical device regulations is ...

AXIM Biotechnologies, Inc. (“AXIM” or the “Company”) (OTC:AXIM), a diagnostic and biotechnology company advancing clinically validated solutions for ocular and inflammatory diseases, today announced ...